Actionable news
All posts from Actionable news

Celator® Pharmaceuticals to Report First Quarter 2016 Financial Results on May 10, 2016

EWING, N.J., May 3, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. CPXX, -4.77% today announced that it will host a conference call and live audio webcast on Tuesday, May 10, 2016 at 4:30 p.m. ET to report first quarter 2016 financial results.

To participate in the conference call, please dial (877) 303-6316 (domestic) or (650) 521-5176 (international) and refer to conference ID 5850159. The live webcast of the call can be accessed in the Investors section of the Company's website at An archived webcast will be available on the Company's website beginning approximately two hours after the event.

About Celator Pharmaceuticals, Inc.

Celator Pharmaceuticals, Inc., with locations in Ewing, N.J., and Vancouver, B.C., is an oncology-focused biopharmaceutical company that is transforming the science of combination therapy, and developing products to improve patient outcomes in cancer. Celator's proprietary technology platform, CombiPlex®, enables the rational design and rapid evaluation of optimized combinations of anti-cancer drugs, incorporating traditional chemotherapies as well as molecularly...